Form 4 for BLFS BIOLIFE SOLUTIONS INC
Accepted 2021-07-01 00:00:00 ET · period of report 2021-06-29 · accession 0001437749-21-016269 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-07-01 | 2021-06-29 | BLFS | Mathew Aby J. | EVP, Chief Scientific Off | S - Sale | $43.75 | -715 | 209.6K | -0.3% | -$31.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-06-29 | S | D | 715 | $43.75 | 209,589 | D | — | — |